
Jeplus.in
Purchase All Medicines.Get 10% Offer

Pharma Tech
The FDA's latest efforts to curb the illicit US medicines trade are primarily centred around weight loss and fat-reducing peptides.

Pharma Tech
The antibody is designed to provide broad coverage across B-cell mediated diseases and might have autoimmune therapeutic potential.

Pharma Tech
Karsten Eastman, CEO of Sethera Therapeutics, discusses developments in peptides from cutting-edge innovation to mass consumption.

Pharma Tech
As soaring biologics demand drives new aseptic facility construction, manufacturers face stricter regulatory scrutiny.

Express Pharma
The inspection was conducted from August 24 to September 1, 2026 The post Gland Pharma’s Visakhapatnam facilities clear USFDA inspection with zero observations appeared first on Express Pharma.
Sponsored content

Purchase All Medicines.Get 10% Offer
News
ET Pharma
Sep 3, 2026, 1:43 AM
The company said it plans to transfer laboratories for biological cell banks, analytical ​testing procedures and technical development activities from Kleinbasel, an area of Basel, to its main ​campus in the city by the end of 2028.
ET Pharma
Sep 3, 2026, 1:41 AM
Sales of anti-infectives rose to ₹2,359 crore in July 2026 from ₹2,107 crore in June, while those of antibacterials increased to ₹2,109 crore from ₹1,883 crore. Sales of both the segments were up 6% from July 2025.
Pharma Tech
Sep 2, 2026, 4:22 PM
The FDA's latest efforts to curb the illicit US medicines trade are primarily centred around weight loss and fat-reducing peptides.
Pharma Tech
Sep 2, 2026, 3:06 PM
The antibody is designed to provide broad coverage across B-cell mediated diseases and might have autoimmune therapeutic potential.
PharmaShots
Sep 2, 2026, 12:30 PM
Shots: Ref: Globenewswire |  Image: uniQure  | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post uniQure Reports the US FDA BLA Submission for Ifezuntirgene Inilparvovec to Treat Huntington’s Disease appeared first on PharmaShots.
PharmaShots
Sep 2, 2026, 11:30 AM
Shots: Ref: Businesswire |  Image: Evotec & Plectonic  | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Evotec and Plectonic Partner on Next-Generation T-Cell Engagers for Solid Tumors appeared first on PharmaShots.
News
Google News
Sep 3, 2026, 3:20 AM
Trump and RFK Jr.'s health industry deals haven't been enforced and are at risk of vanishing  Medical Xpress
Google News
Sep 3, 2026, 2:47 AM
India’s pharma exports rise 6.8% in Q1 despite West Asia disruptions: Pharmexcil  BusinessLine
Google News
Sep 3, 2026, 2:29 AM
Robotics & AI in Pharmaceutical Manufacturing  Design News
Google News
Sep 3, 2026, 1:45 AM
Gender Equality: Equal Opportunities  QS GEN
Google News
Sep 3, 2026, 1:15 AM
Insilico Medicine included in the HKEX Tech 100 Index, drawing attention to opportunities in AI value chain  EurekAlert!
Google News
Sep 3, 2026, 12:57 AM
Doctor of Pharmacy student selected for national opportunity  Campbell University News
Google News
Sep 3, 2026, 12:35 AM
CHA Biotech Joins State-Funded Cell Therapy Quality Platform Project  en.sedaily.com
Google News
Sep 2, 2026, 10:00 PM
Trump Expands Drug Pricing Deals With 9 Pharma Companies, Bringing Total to 26 — RFK Jr. Details 'Very, Very Emotional' Conversations With President  Yahoo Finance
Google News
Sep 2, 2026, 9:54 PM
Pharma clinical research firm eyes former Elanco building in Greenfield  Inside INdiana Business
Sponsored placement

Purchase All Medicines.Get 10% Offer